Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations.

Augestad KM, Merok MA, Ignatovic D.

Clin Med Insights Oncol. 2017 Feb 16;11:1179554917690766. doi: 10.1177/1179554917690766. eCollection 2017. Review.

2.

Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma.

Rakislova N, Montironi C, Aldecoa I, Fernandez E, Bombi JA, Jimeno M, Balaguer F, Pellise M, Castells A, Cuatrecasas M.

J Transl Med. 2017 Jan 14;15(1):14. doi: 10.1186/s12967-016-1114-3.

3.

Molecularly determined total tumour load in lymph nodes of stage I-II colon cancer patients correlates with high-risk factors. A multicentre prospective study.

Aldecoa I, Atares B, Tarragona J, Bernet L, Sardon JD, Pereda T, Villar C, Mendez MC, Gonzalez-Obeso E, Elorriaga K, Alonso GL, Zamora J, Planell N, Palacios J, Castells A, Matias-Guiu X, Cuatrecasas M.

Virchows Arch. 2016 Oct;469(4):385-94. doi: 10.1007/s00428-016-1990-1. Epub 2016 Jul 22.

4.

Endoscopic tattooing of early colon carcinoma enhances detection of lymph nodes most prone to harbor tumor burden.

Aldecoa I, Montironi C, Planell N, Pellise M, Fernandez-Esparrach G, Gines A, Delgado S, Momblan D, Moreira L, Lopez-Ceron M, Rakislova N, Martinez-Palli G, Balust J, Bombi JA, de Lacy A, Castells A, Balaguer F, Cuatrecasas M.

Surg Endosc. 2017 Feb;31(2):723-733. doi: 10.1007/s00464-016-5026-3. Epub 2016 Jun 20.

5.

Non-surgical factors influencing lymph node yield in colon cancer.

Wood P, Peirce C, Mulsow J.

World J Gastrointest Oncol. 2016 May 15;8(5):466-73. doi: 10.4251/wjgo.v8.i5.466. Review.

6.

A new simple morphology-based risk score is prognostic in stage I/II colon cancers.

Märkl B, Märkl M, Schaller T, Mayr P, Schenkirsch G, Kriening B, Anthuber M.

Cancer Med. 2016 Jul;5(7):1492-501. doi: 10.1002/cam4.737. Epub 2016 May 11.

7.

Lymph nodes' evaluation in relation to colorectal cancer staging among African Americans.

Ashktorab H, Ogundipe T, Brim H, Shahnazi A, Laiyemo AO, Lee E, Shokrani B, Nouraie M.

BMC Cancer. 2015 Dec 16;15:976. doi: 10.1186/s12885-015-1946-x.

8.

Stage migration vs immunology: The lymph node count story in colon cancer.

Märkl B.

World J Gastroenterol. 2015 Nov 21;21(43):12218-33. doi: 10.3748/wjg.v21.i43.12218. Review.

9.

The number of metastatic lymph nodes exhibiting poorly differentiated clusters predicts survival in patients with pStage III colorectal cancer.

Kinoshita O, Kishimoto M, Murayama Y, Kuriu Y, Nakanishi M, Sakakura C, Otsuji E, Yanagisawa A.

Int J Colorectal Dis. 2016 Feb;31(2):283-90. doi: 10.1007/s00384-015-2393-5. Epub 2015 Sep 28.

10.

The size of retrieved lymph nodes correlates with the number of retrieved lymph nodes and is an independent prognostic factor in patients with stage II colon cancer.

Okada K, Sadahiro S, Suzuki T, Tanaka A, Saito G, Masuda S, Haruki Y.

Int J Colorectal Dis. 2015 Dec;30(12):1685-93. doi: 10.1007/s00384-015-2357-9. Epub 2015 Aug 12.

11.

Prognostic Effect of Ultra-Staging Node-Negative Colon Cancer Without Adjuvant Chemotherapy: A Prospective National Cancer Institute-Sponsored Clinical Trial.

Protic M, Stojadinovic A, Nissan A, Wainberg Z, Steele SR, Chen DC, Avital I, Bilchik AJ.

J Am Coll Surg. 2015 Sep;221(3):643-51; quiz 783-5. doi: 10.1016/j.jamcollsurg.2015.05.007. Epub 2015 May 18.

12.

Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapy.

Wasserberg N, Kundel Y, Purim O, Keidar A, Kashtan H, Sadot E, Fenig E, Brenner B.

Radiat Oncol. 2014 Oct 22;9:233. doi: 10.1186/s13014-014-0233-3.

13.

Comparison of the clinical outcomes of laparoscopic-assisted versus open surgery for colorectal cancer.

Chen K, Zhang Z, Zuo Y, Ren S.

Oncol Lett. 2014 Apr;7(4):1213-1218. Epub 2014 Feb 7.

14.

Colorectal cancer and lymph nodes: the obsession with the number 12.

Li Destri G, Di Carlo I, Scilletta R, Scilletta B, Puleo S.

World J Gastroenterol. 2014 Feb 28;20(8):1951-60. doi: 10.3748/wjg.v20.i8.1951. Review.

15.

The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.

Scabini S, Montecucco F, Nencioni A, Zoppoli G, Sartini M, Rimini E, Massobrio A, De Marini L, Poggi A, Boaretto R, Romairone E, Ballestrero A, Ferrando V.

World J Surg Oncol. 2013 Nov 18;11:292. doi: 10.1186/1477-7819-11-292.

16.

Epigenetics and colorectal cancer pathogenesis.

Bardhan K, Liu K.

Cancers (Basel). 2013 Jun 5;5(2):676-713. doi: 10.3390/cancers5020676.

17.

Debating deposits: an interobserver variability study of lymph nodes and pericolonic tumor deposits in colonic adenocarcinoma.

Rock JB, Washington MK, Adsay NV, Greenson JK, Montgomery EA, Robert ME, Yantiss RK, Lehman AM, Frankel WL.

Arch Pathol Lab Med. 2014 May;138(5):636-42. doi: 10.5858/arpa.2013-0166-OA. Epub 2013 Jul 31.

18.

Prognostic impact of the metastatic lymph node ratio on survival in rectal cancer.

Attaallah W, Gunal O, Manukyan M, Ozden G, Yegen C.

Ann Coloproctol. 2013 Jun;29(3):100-5. doi: 10.3393/ac.2013.29.3.100. Epub 2013 Jun 30.

19.

Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series.

Merok MA, Ahlquist T, Røyrvik EC, Tufteland KF, Hektoen M, Sjo OH, Mala T, Svindland A, Lothe RA, Nesbakken A.

Ann Oncol. 2013 May;24(5):1274-82. doi: 10.1093/annonc/mds614. Epub 2012 Dec 12.

20.

The complexity of the count: considerations regarding lymph node evaluation in colorectal carcinoma.

Denham LJ, Kerstetter JC, Herrmann PC.

J Gastrointest Oncol. 2012 Dec;3(4):342-52. doi: 10.3978/j.issn.2078-6891.2012.027.

Supplemental Content

Support Center